Sagent Pharmaceuticals, Inc. (SGNT) Tops Q3 EPS by 12c; Guides FY14 Revs
Tweet Send to a Friend
Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) reported Q3 EPS of $0.11, $0.12 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
